China · Delayed Price · Currency is CNY Xiangxue Pharmaceutical Statistics
Total Valuation
SHE:300147 has a market cap or net worth of CNY 6.41 billion. The enterprise value is 8.09 billion.
| Market Cap | 6.41B |
| Enterprise Value | 8.09B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300147 has 661.28 million shares outstanding. The number of shares has increased by 0.63% in one year.
| Current Share Class | 661.28M |
| Shares Outstanding | 661.28M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | -1.45% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 3.18% |
| Float | 483.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.19 |
| PB Ratio | -76.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 47.08 |
| P/OCF Ratio | 41.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 70.33, with an EV/FCF ratio of 59.43.
| EV / Earnings | n/a |
| EV / Sales | 5.29 |
| EV / EBITDA | 70.33 |
| EV / EBIT | n/a |
| EV / FCF | 59.43 |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | 12.50 |
| Debt / FCF | 10.56 |
| Interest Coverage | -0.24 |
Financial Efficiency
Return on equity (ROE) is -217.95% and return on invested capital (ROIC) is -5.77%.
| Return on Equity (ROE) | -217.95% |
| Return on Assets (ROA) | -0.63% |
| Return on Invested Capital (ROIC) | -5.77% |
| Return on Capital Employed (ROCE) | -92.56% |
| Weighted Average Cost of Capital (WACC) | 8.69% |
| Revenue Per Employee | 574,216 |
| Profits Per Employee | -531,885 |
| Employee Count | 2,662 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 3.41 |
Taxes
In the past 12 months, SHE:300147 has paid 41.71 million in taxes.
| Income Tax | 41.71M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.22% in the last 52 weeks. The beta is 0.49, so SHE:300147's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +20.22% |
| 50-Day Moving Average | 10.02 |
| 200-Day Moving Average | 9.93 |
| Relative Strength Index (RSI) | 49.51 |
| Average Volume (20 Days) | 8,173,925 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300147 had revenue of CNY 1.53 billion and -1.42 billion in losses. Loss per share was -2.16.
| Revenue | 1.53B |
| Gross Profit | 425.11M |
| Operating Income | -71.10M |
| Pretax Income | -1.35B |
| Net Income | -1.42B |
| EBITDA | 110.78M |
| EBIT | -71.10M |
| Loss Per Share | -2.16 |
Balance Sheet
The company has 144.74 million in cash and 1.44 billion in debt, with a net cash position of -1.29 billion or -1.95 per share.
| Cash & Cash Equivalents | 144.74M |
| Total Debt | 1.44B |
| Net Cash | -1.29B |
| Net Cash Per Share | -1.95 |
| Equity (Book Value) | -84.09M |
| Book Value Per Share | -0.72 |
| Working Capital | -5.01B |
Cash Flow
In the last 12 months, operating cash flow was 156.09 million and capital expenditures -19.99 million, giving a free cash flow of 136.09 million.
| Operating Cash Flow | 156.09M |
| Capital Expenditures | -19.99M |
| Depreciation & Amortization | 181.88M |
| Net Borrowing | -15.63M |
| Free Cash Flow | 136.09M |
| FCF Per Share | 0.21 |
Margins
Gross margin is 27.81%, with operating and profit margins of -4.65% and -92.63%.
| Gross Margin | 27.81% |
| Operating Margin | -4.65% |
| Pretax Margin | -88.14% |
| Profit Margin | -92.63% |
| EBITDA Margin | 7.25% |
| EBIT Margin | -4.65% |
| FCF Margin | 8.90% |
Dividends & Yields
SHE:300147 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.63% |
| Shareholder Yield | -0.63% |
| Earnings Yield | -22.10% |
| FCF Yield | 2.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 14, 2014. It was a forward split with a ratio of 1.3.
| Last Split Date | Jul 14, 2014 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHE:300147 has an Altman Z-Score of -0.86 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.86 |
| Piotroski F-Score | 4 |